Please Wait...

Upcoming Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

Join us for our upcoming webinar on July 25th during which Sukrit Singh and Dr. Ayesha Hussain, both pharmacovigilance experts who are also Associate Directors of CRM at Bioclinica, Inc., will present and discuss case studies illustrating how market authorization holders and CROs are becoming partners of choice in the ever-changing world of pharmacovigilance outsourcing.

The need to comply with regulatory requirements is increasing with the demand for new therapies across the pharmaceutical industry, which is seeking newer, more efficient ways of managing the growing load of adverse event data. Outsourcing is becoming a possible solution for short or long-term needs for more companies because of the:

  • Unavailability of the necessary system components for timely pharmacovigilance implementation by first-time marketing authorization holders.
  • Need for larger companies to streamline processes and reduce wastage, for a more robust and compliant reporting system.

The presented case studies will provide examples of:

  • Streamlining and globalizing processes to increase compliance rates with regulatory agencies.
  • Increasing productivity and reducing time to market.
  • Focusing on data quality.
  • Employing business excellence strategies to identify more effective ways of presenting accurate and meaningful data.
  • Employing tools that help market authorization holders achieve ease of operation and better transparency.

To join us for this webinar and learn more, register here.

Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (6 days ago)
#Pharma & CROs: Ck it out! Enterprise tools for site payments automation & reconciliation. https://t.co/LFri5Kv0WC
bioclinica (6 days ago)
Can having a geographically diverse network of high performing sites mean fewer sites are needed in a trial? Can ha… https://t.co/tZYvWrNzHg
bioclinica (6 days ago)
Confidence is a good thing ─ especially in the clinical supply chain for global clinical trials. Here’s how accurat… https://t.co/70VwXCwuWw
bioclinica (1 week ago)
#Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most… https://t.co/3YNpB9hTXs
bioclinica (2 weeks ago)
Announcing our new Chief of Staff @bioclinica Adrienne Rossi! Also welcoming President Bioclinica Site Network Eliz… https://t.co/toB9yk534k
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen